Readings Flashcards

(14 cards)

1
Q

What is the evidence regarding GLP 1 agonists and sarcopenia or frailty?

A

There is no evidence to support sarcopenia or frailty. The reduction in FFM/SMM is less than fat mass and improves overall composition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What happends with repeated cycles of weight loss/gain?

A

Fat mass is regained and not FFM which results in overall metabolic risks due to adiposity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How much weight regain occurs 1 year after ceasing GLP 1 agonists?

A

One half to two thirds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What evidence is there for fish oil in CVD?

A

Low quality eveidence shows it may slightly reduce CVD event risk, CHD mortality and arrhythmia but moderate-high quality shows little to no evidence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Evidence for vitamin D and calcium in premenopausal women?

A

Does not support the isolated or combined use of calcium and vitamin
D supplementation in healthy premenopausal women as a public health intervention to improve BMD
in the total hip or lumbar spine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does fish oil work in theory?

A

lowering the blood pressure; altering the lipid profile, especially reduced serum triglyceride concentration;
modulating arterial lipoprotein lipase levels; reducing thrombotic tendency; producing anti-inflammatory
effects and anti-arrhythmic effects; improving vascular endothelial function and insulin sensitivity; and
increasing plaque stability and paraoxonase levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is there evidence for regarding vaping?

A

Substantial evidence for dependance in non-smokers
Limited evidence of higher abuse liability then NRT
Moderate evidence that vaping causes increased HR, bp, and arterial stiffness immediately after use in smokers
Conclusive evidence:
- it casues respiratory disease
- burns and injuries that may result in death
- poisoning and nicotine toxicity
- airborne particulate indoors, fires and environmental waste.
- can lead to seizures
Moderate evidence of less severe AE (cough, dizziness, headache).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does evidence show sick day management needs?

A

Requires patient education on self-management strategies, communication with health care
providers, and tools to translate the guidance into practice.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What interventions are effective for shingles PHN?

A

regular anti-neuropathic drug administration accompanied by interventional therapies at an early stage is the best choice to treat patients with PHN. Appropriate combinations
of d/t interventions show improved pain relief

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the evidence for triple therapy?

A

Reduces FEV1 trough levels, severe exacerbations, no effect on mortality or AE but increase pneumonia events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which agents have high evidence quality for neuropathic pain?

A

SNRRs (duloxetine), gabapentin and pregabalin, amitritpyline has moderate evidence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which agent for neuropathic pain has high NNH?

A

Gabapentin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Order of NNT for neuropathic pain?

A

Amitriptyline (moderate quality), duloxetine, gabapentin and pregabalin are equal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effectiveness of NRT, varenicline and buproprion?

A

Buproprion and single NRT is less effective than combined NRT and varenicline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly